Litigation Details for Sanofi v. Watson Laboratories Inc. (D. Del. 2014)
✉ Email this page to a colleague
Sanofi v. Watson Laboratories Inc. (D. Del. 2014)
| Docket | ⤷ Subscribe | Date Filed | 2014-02-26 |
| Court | District Court, D. Delaware | Date Terminated | 2016-09-22 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Parties | AMNEAL PHARMACEUTICALS OF NEW YORK LLC; GLENMARK PHARMACEUTICALS INC. USA | ||
| Patents | 7,323,493; 8,318,800; 8,410,167; 8,602,215 | ||
| Attorneys | Julia M. Johnson; Matthew V. Anderson | ||
| Firms | Duane Morris LLP; Phillips, McLaughlin & Hall, P.A. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Sanofi v. Watson Laboratories Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Subscribe .
Details for Sanofi v. Watson Laboratories Inc. (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2015-04-03 | 117 | Construction Brief Regarding U.S. Patent Nos. 8,318,800 and 7,323,493 filed by Sanofi, Sanofi-Aventis U.S… 22 September 2016 1:14-cv-00264 830 Patent None District Court, D. Delaware | External link to document | |
| 2015-04-15 | 119 | Inc.'s Counterclaims Pertaining to U.S. Patent No. 7,323,493 Pursuant to F.R.C.P. 41(a)(1)(A)(ii), by… 22 September 2016 1:14-cv-00264 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
